January 16, 2024 · Form 4 insider transaction
Dickinson Andrew D sold 5,000 shares of Gilead Sciences, Inc. at $85.78 per share, a transaction worth $428.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2023.